tyrosine kinase inhibitor Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (2)

Phase 1/2 (1)
Unknown (1)

Interventional (1)
Observational (1)

Huiqiang Huang (1)
The First Affiliated Hospital of Zhengzhou University (1)

No (2)

No (2)

Adult (18+) (2)

I am/have/had

I am/have/hadtyrosine

I am/have/haddiffuse large b-cell lymphoma

I am/have/hadserum bilirubin

I am/have/hadliver metastasis

I am/have/hadimmunodeficiency

I am/have/hadglioma

I am/have/hadlymphoma

I am/have/hadanticoagulants

I am/have/hadblood transfusion

I am/have/hadprothrombin time (pt)

I am/have/hadmetastasis

I am/have/hadfollicular lymphoma grade iiib

I am/have/hadhigh-grade lymphoma

I am/have/hadebv-positive dlbcl, nos

I am/have/hadneutrophil count

I am/have/hadpositron emission tomography

I am/have/hadpulse oximetry

I am/have/hadpulmonary function test

I am/have/hadtubal ligation

I am/have/hadthyroid dysfunction

added new label for I am/have/had

more

I am looking for

I am looking fortyrosine

I am looking forcamrelizumab

I am looking forcolony stimulating factor

I am looking fororal contraceptives

I am looking forapatinib

I am looking forgrowth factor

I am looking forrituximab

I am looking forg-csf

I am looking forvegf

I am looking for18f-fdg

I am looking forvascular endothelial growth factor

I am looking forgranulocyte colony stimulating factor

I am looking foranticoagulants

added new label for I am looking for

more

Advanced Filters

Loading...

Found 2 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

Camrelizumab in Combination With Apatinib in Refractory and Relapsed DLBCL

This study will evaluate the efficacy and safety of camrelizumab in combination with apatinib in in patients with relapsed or refractory diffuse large B cell lymphoma failed from second line chemotherapy.

diffuse large b-cell lymphoma

serum bilirubin

immunodeficiency

18f-fdg

lymphoma

0 views
19 Feb, 2024
1 location

For Seniors
For adults
Recruiting in 100s
Observational Study
all
Recruiting

Prediction of Therapeutic Response of Apatinib in Recurrent Gliomas

Apatinib, also known as YN968D1, is a small-molecule tyrosine kinase inhibitor (TKI) that selectively binds to and inhibits vascular endothelial growth factor receptor 2 (VEGFR-2). This study aims to collect clinical, radiological and histopathology imaging including detailed radiological data, survival data, clinical parameters, molecular pathology and images of HE slices …

tyrosine

metastasis

growth factor

liver metastasis

hypertension

0 views
19 Feb, 2024
1 location

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2026 All rights reserved.